the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib
Clinical trial NCT06370416 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06370416
- Sponsor
- Henan Cancer Hospital
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-02
- Primary completion
- 2026-01-30
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.